MENU
+Compare
OASMY
Stock ticker: OTC
AS OF
Jun 11 closing price
Price
$0.02
Change
-$0.00 (-0.00%)
Capitalization
12.82M

OASMY VIVESTO AB Forecast, Technical & Fundamental Analysis

Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer... Show more

OASMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OASMY with price predictions
Jul 03, 2025

OASMY in upward trend: price rose above 50-day moving average on June 03, 2025

OASMY moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 19 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for OASMY crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.001) is normal, around the industry mean (62.813). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). OASMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.353) is also within normal values, averaging (19.290).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OASMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OASMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
OASMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

OASMY paid dividends on April 04, 2022

VIVESTO AB OASMY Stock Dividends
А quarterly dividend of $0.00 per share was paid with a record date of April 04, 2022, and an ex-dividend date of March 25, 2022. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Gustav III:s Boulevard 46
Phone
+46 18505440
Employees
18
Web
https://www.vivesto.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUKPY6.550.01
+0.17%
Metso OYJ
AAMMF0.24N/A
N/A
Almadex Minerals Ltd.
CMGMF7.76N/A
N/A
Chemring Group Plc.
GENTF11.15N/A
N/A
G5 Entertainment AB
SBNYL3.75-0.05
-1.32%
Signature Bank (New York, NY)

OASMY and Stocks

Correlation & Price change

A.I.dvisor tells us that OASMY and MVMDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and MVMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
MVMDF - OASMY
9%
Poorly correlated
-5.04%
MKGAF - OASMY
4%
Poorly correlated
+0.12%
PCLOF - OASMY
2%
Poorly correlated
+37.05%
NDVAF - OASMY
2%
Poorly correlated
N/A
OMID - OASMY
2%
Poorly correlated
N/A
More

Groups containing OASMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
Pharmaceuticals
category (297 stocks)
-3%
Poorly correlated
+0.49%
Pharmaceuticals: Other
category (203 stocks)
-4%
Poorly correlated
+0.78%